MIRA
INFORM REPORT
|
Report Date : |
26.07.2012 |
IDENTIFICATION DETAILS
|
Name : |
INTEC PRODUCTS, INC. |
|
|
|
|
Registered Office : |
No. 332, Xinguang Road, Xinyang Industrial Zone, Haicang, Xiamen, Fujian Province, 361022 Pr |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
14.12.1989 |
|
|
|
|
Com. Reg. No.: |
350200400006388 |
|
|
|
|
Legal Form : |
Wholly Foreign-Owned Enterprise |
|
|
|
|
Line of Business : |
manufacturing and selling biochemical reagents |
|
|
|
|
No. of Employees : |
500 |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2012
|
Country Name |
Previous Rating (31.12.2011) |
Current Rating (31.03.2012) |
|
China |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Company name & address
InTec PRODUCTS, INC.
No. 332, xinguang
road, xinyang industrial zone, haicang,
xiamen, fujian PROVINCE,
361022 PR CHINA
TEL: 86 (0)
592-6807188 FAX: 86 (0) 592-6519159
EXECUTIVE SUMMARY
INCORPORATION DATE : dec. 14, 1989
REGISTRATION NO. : 350200400006388
REGISTERED LEGAL FORM :
WHOLLY FOREIGN-OWNED enterprise
STAFF STRENGTH : 500
REGISTERED CAPITAL : USD 9,460,000
BUSINESS LINE : MANUFACTURING
TURNOVER : n/a
EQUITIES : n/a
PAYMENT : AVERAGE
MARKET CONDITION : average
FINANCIAL CONDITION : N/A
OPERATIONAL TREND : STEADY
GENERAL REPUTATION : AVERAGE
EXCHANGE RATE : CNY
6.37 = USD 1
Adopted abbreviations:
ANS - amount not stated
NS - not stated
SC - subject company (the company inquired by you)
NA - not available
CNY - China Yuan Renminbi
SC was registered as a wholly foreign-owned enterprise at
local Administration for industry & commerce (AIC - the official body of
issuing and renewing business license) on Dec. 14, 1989.
Company Status: Wholly foreign-owned enterprise This form of business in PR
China is defined as a legal person. It is a limited co. established within
the territories of PR China with capital provided totally by the foreign
investors. More than one foreign investor may jointly invest in a wholly
foreign-owned enterprise. The investing party/parties solely exercise
management, reap profit and bear risks and liabilities by themselves. This
form of companies usually have a limited duration is extendible upon
approval of Examination and Approval Authorities.
SC’s registered
business scope includes manufacturing and selling biochemical reagent, base
component, medical equipment, pharmaceutical raw materials
and finished products, such as chemical, biochemical and biological engineering
products.
SC is mainly
engaged in manufacturing and selling biochemical reagents.
Mr.
John Gong Lu is legal representative, chairman and general manager of SC at
present.
SC is known to have approx. 500 employees at
present.
SC
is currently operating at the above stated address, and this address houses its
operating office and factory in the industrial zone
of Xiamen. The detailed information of the premise is unspecified.
http://www.intecasi.com The
design is professional and the content is well organized. At present it is in
both Chinese and English versions.
E-mail: intecproducts@asintec.com
No significant changes were found during our checks with the
local Administration for Industry and Commerce.
Quality Management System takes the requirements embodied in the
following into account:
Ÿ
ISO13485 Certified
Ÿ
FDA audited GMP guidelines
Ÿ
Demonstrates a long track record with regulatory
bodies of individual countries.
Ÿ
CE Certified(self-declaration)
MAIN SHAREHOLDERS:
Name %
of Shareholding
Intec Holdings International Limited (Hong Kong) 100
CR No.: 0689344
Company Status:
Private
Active Status:
Live
Legal
representative, Chairman and General manager:
Mr. John Gong Lu is currently responsible for
the overall management of SC.
Working
Experience(s):
At present Working in SC as legal representative, chairman and general manager.
SC is mainly
engaged in manufacturing and selling biochemical reagents.
SC’s products mainly
include: biochemical reagents and blood glucose meter, etc.
SC sources its materials 90%
from domestic market, and 10% from overseas market. SC sells 70% of its
products in domestic market, and 30% to overseas market.
The buying terms of SC include Check, T/T, L/C and Credit of
30-60 days. The payment terms of SC include Check, T/T, L/C and Credit of 30-60
days.
Note: SC’s management declined to release its customer and supplier
details.
SC
is not known to have any subsidiary at present.
Overall payment appraisal :
( ) Excellent (
) Good (X) Average (
) Fair ( ) Poor
( ) Not yet determined
The appraisal serves as a reference to reveal SC's payments habits and
ability to pay. It is based on the 3
weighed factors: Trade payment
experience (through current enquiry with SC's suppliers), our delinquent
payment and our debt collection record concerning SC.
Trade payment experience : SC did not
provide any name of trade/service suppliers and we have no other sources to
conduct the enquiry at present.
Delinquent
payment record : None in our database.
Debt collection record :No overdue amount owed by SC was placed to us for
collection within the last 6 years.
Website sources:
Agricultural Bank of China Xiamen Lianqian Sub-branch
AC#386001040001580
Relationship:
Normal
SC’s financial
reports were not found during our checks with the local Administration for
Industry and Commerce.
SC’s management declined to release any financial information.
SC is considered an old-established business in medium size.
Taking into consideration of SC’s general performance, reputation as well as
market conditions we would rate SC as an average credit risk company.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.56.38 |
|
UK Pound |
1 |
Rs.87.44 |
|
Euro |
1 |
Rs.68.05 |
INFORMATION DETAILS
|
Report Prepared
by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.